Utilizing RWE and HEOR Throughout the Product Lifecycle: From Product Positioning to Market Access and Reimbursement
Author(s)
Speakers: Kathy Belk, BA, Lumen Value & Access – a Healthcare Consultancy Group Company, New York City, NY, USA Koen Degeling, PhD, MSc, BSc, Lumen Value & Access – a Healthcare Consultancy Group Company, New York, NY, USA; Ramiro Eugenio Gilardino, MD, MHS, MSc, Lumen Value & Access - A Healthcare Consultancy Group Co., New York, NY, USA; Lucinda Orsini, DPM, MPH, COMPASS Pathways, Skillman, NJ, USA
Presentation Documents
The role of real-world evidence (RWE) and health economics and outcomes research (HEOR) for market access and reimbursement is well established, but there is an increasing interest in utilizing RWE and HEOR earlier in the product lifecycle, adopting a more proactive approach towards supporting product development and evidence generation. This HEOR theater will open with an industry perspective on remaining challenges throughout the product development process, followed by presentations and a discussion on how an integrated and lifecycle approach towards RWE, HEOR, and market access and reimbursement can address these challenges.
Conference/Value in Health Info
2022-05, ISPOR 2022, Washington, DC, USA
Code
136
Topic
Real World Data & Information Systems